Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

See it in 1 second, act in 60: Eschbach’s take on how visual factories enable measurable decisions

By Brian Buntz | September 26, 2025

Pharma plants are awash in data. There are myriad sources: MES for execution status, LIMS (QC results), process historians (equipment conditions), QMS (quality/deviations) to name just a few, but release decisions still stall when those sources disagree or lack an owner.

To deal with the chaos, eschbach’s visual factory centers daily work on SQDCP boards (the lean tool referring to Safety, Quality, Delivery, Cost, People) that display target-versus-actual, convert gaps into owned actions with due dates. “It’s more than just visualizing those graphs,” emphasizes CEO Andreas Eschbach. “It’s getting the data into the hand of the people, getting the right information to the right people at the right time, and making them work with it.” It can escalate issues from tier-1 shift huddles to tier-5 leadership so problems don’t linger. Tiles show simple trends. Deviations can be turned into actions with an owner and deadline. Notifications can go, for instance, to operators’ mobile devices or a display. From there, QA and maintenance can acknowledge or hand off to the next shift without losing context.

See it in 1 second, act in 60

Eschbach describes the operating rule behind the approach as “1-10-60.” That is: one second to see status, ten to locate the issue, and sixty to decide on countermeasures. If a screen takes longer than that to parse, teams can simplify the layout or reduce KPIs. 

“A second to see if you’re winning or losing, 10 seconds to grasp the issue, 60 seconds to decide the measures.” —Andreas Eschbach

Andreas Eschbach

Andreas Eschbach

Sites that avoid dashboard sprawl can set clear templates, cap metrics per board, and name a board owner accountable for its clarity and upkeep. Under the hood, the boards can draw on existing systems rather than requiring new data pipes. Process historians, for instance, can supply machine states and downtime codes for OEE and loss accounting; MES adds batch context and release gates; LIMS/QMS provide test results and deviations. Most sites already have these systems running. The challenge isn’t getting new data but connecting what’s already there.

Where IIoT is present, signals may arrive via MQTT or OPC UA, but the historian typically remains the system of record. Time-stamped tiles link back to source for drill-downs, and actions carry owners and timestamps to support auditability in regulated environments. The prerequisite is data hygiene: common equipment IDs and batch keys across systems. Factories that struggle with quality or throughput problems don’t tend to be short on data; they tend to be short on alignment. The systems are often siloed, and people fill the gaps with, say, Excel and SharePoint.

Where AI fits

eschbach’s AI layer, SAMI (Shiftconnector Artificial Manufacturing Intelligence), focuses on unstructured text in shift logs and handovers. The remit is explicit: link real problems to recorded solutions; don’t invent them. That is, SAMI is designed to connect known fixes to current issues to documented mitigations across sites (and languages) to avoid AI hallucinations.

In practice, SAMI does a few things: AI shift summaries posted to boards and delivered as notifications so teams see the day’s exceptions rather than routine noise; a solution finder that connects current issues to past, recorded mitigations; and a mobile chat interface so frontline staff can retrieve context in their language, on the spot. As Eschbach put it, sites “usually see … almost 100 records created in 24 hours,” with AI summarizing that stream down to what actually matters, filtering routine activity and highlighting exceptions.

This matters for tacit knowledge capture. An operator might never write “viscosity” in a log, but they’ll write “it feels like honey” or “it’s like cream.” SAMI surfaces those semantics so anecdotal notes become a usable knowledge base.

Cutting latency of batch release

Batch release is often a race against latency: waiting on tests, deviations, and signatures across LIMS, QMS and MES. Visualizing status across these systems reduces wait time by making blockers explicit and assignable. A control-tower view helps departments see interdependencies and act on them.

As Eschbach put it, pharma clients focus on how they can help with a faster time to patient by optimizing their batch release so that everyone knows what matters at the moment to release a certain batch. The success metric is behavioral: faster handovers, clearer ownership, and fewer ping-pong escalations rather than just more charts.havioral: faster handovers, clearer ownership, and fewer ping-pong escalations rather than just more charts.

Keeping people in the loop

The philosophy is human-in-the-loop: offload retrieval and correlation so people can focus on judgment and GMP-compliant action. Human-in-the-loop will be with pharma for a long time. The aim is to take the robot out of the human.

To keep leadership engaged with the floor, eschbach even includes nudges such as a GEMBA walk randomizer that selects the next topic or area to review, which is often safety, during walks.

Agent-to-agent communication is accelerating. For data transport on the shop floor you’ll see MQTT/OPC UA; for agents, Eschbach notes recent work with the MCP protocol, originally developed by Anthropic. “There is such a powerful world of agent-to-agent communication coming which I would assume is mind-blowing,” Eschbach concluded.


Filed Under: Drug Discovery and Development
Tagged With: agent-to-agent communication, Andreas Eschbach, artificial intelligence (AI), batch release, data visualization, GEMBA walk, GMP, Industrial Internet of Things (IIoT), key performance indicators (KPIs), laboratory information management system (LIMS), lean manufacturing, machine learning, manufacturing execution system (MES), MQTT, natural language processing, OPC UA, Overall Equipment Effectiveness (OEE), Pharma manufacturing, process historians, quality management system (QMS), real-time data, Shiftconnector Artificial Manufacturing Intelligence (SAMI), SQDCP, visual factories
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at [email protected].

Related Articles Read More >

Sai Life Sciences to double process R&D capacity with new Hyderabad facility
How stereo-correct data can de-risk AI-driven drug discovery
Pfizer stock jumps 14% as TrumpRx drug pricing deal eases tariff fears
AUTOMA+ 2025 to cover pharma automation and digitalization trends
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE